Vikram Purohit analyst MORGAN STANLEY

Currently out of the existing stock ratings of Vikram Purohit, 88 are a BUY (35.63%), 154 are a HOLD (62.35%), 5 are a SELL (2.02%).

Vikram Purohit

Work Performance Price Targets & Ratings Chart

Analyst Vikram Purohit, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 58.52% that have a potential upside of 43.31% achieved within 211 days.

Vikram Purohit’s has documented 496 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on ARQT, Arcutis Biotherapeutics at 06-Aug-2026.

Wall Street Analyst Vikram Purohit

Analyst best performing recommendations are on TAL (TAL EDUCATION GROUP).
The best stock recommendation documented was for TAL (TAL EDUCATION GROUP) at 6/1/2021. The price target of $35 was fulfilled within 2 days with a profit of $5.51 (13.6%) receiving and performance score of 68.01.

Average potential price target upside

AXSM Axsome Therapeutics CERT Certara FHTX Foghorn Therapeutics HOOK Hookipa Pharma INCY yte KYMR Kymera Therapeutics RDUS Schnitzer Steel Industries SAGE Sage Therapeutic TALS Talaris Therapeutics TBPH Theravance Biopharma EVLO Evelo Biosciences EXAI Exscientia Ltd ADR TIL Instil Bio RGNX Regenxbio SDGR Schrodinger ARQT Arcutis Biotherapeutics ASND Ascendis Pharma AS AKLI Akili HALO Halozyme Therapeutics BMRN Biomarin Pharmaceutical CMPS Compass Pathways Plc GMAB Genmab AS RXRX Recursion Pharmaceuticals ABVX Abivax SA American Depositary Shares SLRN ACELYRIN, INC. Common Stock ABSI Absci Corp ARGX argenx NV ADR TAL TAL Education Group TSVT 2Seventy Bio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Jan-2024

$295

$124.92 (73.45%)

$297

Buy Since 11-Dec-2023

$267

$96.92 (56.98%)

$176

11 days ago
(28-Sep-2026)

5/6 (83.33%)

$80.86 (43.44%)

319

Hold Since 29-Apr-2026

$247

$76.92 (45.23%)

$251

15 days ago
(24-Sep-2026)

8/10 (80%)

$51.91 (26.61%)

152

Buy Since 15-Jan-2024

$258

$87.92 (51.69%)

$258

22 days ago
(17-Sep-2026)

10/12 (83.33%)

$50.22 (24.17%)

171

Buy Since 06-Jun-2018

$290

$119.92 (70.51%)

$290

1 months 9 days ago
(30-Aug-2026)

45/52 (86.54%)

$91.48 (46.08%)

739

Show more analysts

Please expand the browser size to see the chart

Which stock is Vikram Purohit most bullish on?

Potential upside of $12.84 has been obtained for ARQT (ARCUTIS BIOTHERAPEUTICS)

What Year was the first public recommendation made by Vikram Purohit?

On 2016
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?